# iBio, Inc. (IBIO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IBIO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 307.2K | $ -25.33M | $ -19.65M | $ 2.45M | $ 56.56M |
| 2024 | $ 394.2K | $ -20.29M | $ -17.14M | $ 4.00M | $ 13.90M |
| 2023 | $ 54.1K | $ -29.50M | $ -20.75M | $ 17.27M | $ 9.20M |
| 2022 | $ 2.08M | $ -90.63M | $ -56.19M | $ 20.40M | $ 18.82M |
| 2021 | $ 1.59M | $ -33.76M | $ -52.66M | $ 27.71M | $ 90.60M |
| 2020 | $ 2.97M | $ -30.42M | $ -32.64M | $ 32.76M | $ 107.34M |
| 2019 | $ 2.25M | $ -21.88M | $ -19.06M | $ 32.38M | $ -511.0K |
| 2018 | $ 1.14M | $ -22.78M | $ -18.18M | $ 24.99M | $ 11.08M |
| 2017 | $ 618.3K | $ -21.51M | $ -20.30M | $ 25.18M | $ 7.81M |
| 2016 | $ 1.19M | $ -16.51M | $ -16.40M | $ 25.35M | $ 4.15M |
| 2015 | $ 1.35M | $ -10.69M | $ -7.70M | $ 0 | $ 7.88M |
| 2014 | $ 1.97M | $ -7.75M | $ -6.19M | $ 338.0K | $ 9.57M |
| 2013 | $ 877.3K | $ -6.15M | $ -6.44M | $ 0 | $ 7.95M |
| 2012 | $ 1.61M | $ -10.95M | $ -10.00M | $ 0 | $ 3.72M |
| 2011 | $ 1.58M | $ -8.56M | $ -7.49M | $ 0 | $ 305.5K |
| 2010 | $ 0 | $ -17.80M | $ -6.76M | $ 0 | $ 2.18M |
| 2009 | $ 2.37M | $ -4.01M | $ -2.29M | $ 0 | $ 5.21M |
| 2008 | $ 1.85M | $ -3.40M | $ -5.64M | $ 0 | $ 5.18M |
| 2007 | $ 726.5K | $ -1.11M | $ -1.02M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 0.14 |
| Current Ratio | 9.04 |

## Other views

- [Metrics](https://sponda.capital/en/IBIO.md)
- [Charts](https://sponda.capital/en/IBIO/charts.md)
- [Compare](https://sponda.capital/en/IBIO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.
